JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 6, 2005; DOI: 10.1124/jpet.105.091736


0022-3565/05/3153-1354-1361$20.00
JPET 315:1354-1361, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.091736v1
315/3/1354    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, M.
Right arrow Articles by Summers, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, M.
Right arrow Articles by Summers, R. J.

CELLULAR AND MOLECULAR

Functional Domains of the Mouse {beta}3-Adrenoceptor Associated with Differential G Protein Coupling

Masaaki Sato, Dana S. Hutchinson, Tore Bengtsson, Anders Floren, Ülo Langel, Takahiro Horinouchi, Bronwyn A. Evans, and Roger J. Summers

Department of Pharmacology, Monash University, Victoria, Australia (M.S., D.S.H., T.H., B.A.E., R.J.S.); Department of Physiology, Wenner-Gren Institute, Arrhenius Laboratories F3, Stockholm University, Stockholm, Sweden (D.S.H., T.B.); and Department of Neurochemistry and Neurotoxicology, Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden (A.F., U.L.)

Alternative splicing of mouse {beta}3-adrenoceptor transcripts produces an additional receptor isoform ({beta}3b-adrenoceptor) with a C terminus comprising 17 amino acids distinct from the 13 in the known receptor ({beta}3a-adrenoceptor). We have shown that the {beta}3b-adrenoceptor couples to both Gs and Gi, whereas the {beta}3a-adrenoceptor couples only to Gs. To define the regions involved in this differential G protein coupling, we have compared wild-type, truncated, and mutant {beta}3-adrenoceptors. In Chinese hamster ovary cells expressing {beta}3-adrenoceptors truncated at the splicing point, cAMP accumulation with CL316243 [GenBank] [(R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]-propyl]1,3-benzodioxole-2,2-dicarboxylate] increased by 59% following pretreatment with pertussis toxin, suggesting that the C-terminal region of the {beta}3a-adrenoceptor inhibits coupling to Gi. We next utilized the cell-penetrating peptide Transportan 10 (Tp10) to introduce peptides comprising the different C-terminal tail fragments into cells expressing {beta}3a-adrenoceptor, {beta}3b-adrenoceptor, and the truncated {beta}3-adrenoceptor. Treatment with {beta}3a-Tp10 (1 µM) caused cAMP responses to CL316243 [GenBank] in the {beta}3a-adrenoceptor to become pertussis toxin-sensitive and display a 30% increase over control, whereas the other peptides did not affect any receptor. Mutation at a potential tyrosine phosphorylation site (Tyr392Ala {beta}3a-adrenoceptor) did not alter responses or pertussis toxin sensitivity relative to the parent receptor. Surprisingly, a Ser388Ala/Ser389Ala mutant {beta}3b-adrenoceptor became unresponsive to CL316243 [GenBank] while retaining an extracellular acidification rate response to SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]. Our findings suggest that the {beta}3a-adrenoceptor cannot couple to Gi because of conformational changes induced by a protein(s) that interacts with residues in the C-terminal tail or because this protein(s) affects the intracellular localization of the {beta}3a-adrenoceptor.


Received June 28, 2005; accepted September 2, 2005.

Address correspondence to: Roger J. Summers, Department of Pharmacology, P.O. Box 13E, Monash University, Victoria 3800, Australia. E-mail: roger.summers{at}med.monash.edu.au




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Sato, D. S. Hutchinson, B. A. Evans, and R. J. Summers

Mol. Pharmacol., November 1, 2008; 74(5): 1417 - 1428.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Sato, T. Horinouchi, D. S. Hutchinson, B. A. Evans, and R. J. Summers
Ligand-Directed Signaling at the beta3-Adrenoceptor Produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) Relative to Receptor Agonists
Mol. Pharmacol., November 1, 2007; 72(5): 1359 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. He, A. Dibas, T. Yorio, and G. Prasanna
Parallel Signaling Pathways in Endothelin-1-Induced Proliferation of U373MG Astrocytoma Cells
Experimental Biology and Medicine, March 1, 2007; 232(3): 370 - 384.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. S. Dallner, E. Chernogubova, K. A. Brolinson, and T. Bengtsson
{beta}3-Adrenergic Receptors Stimulate Glucose Uptake in Brown Adipocytes by Two Mechanisms Independently of Glucose Transporter 4 Translocation
Endocrinology, December 1, 2006; 147(12): 5730 - 5739.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. R. Lenard, V. Prpic, A. W. Adamson, R. C. Rogers, and T. W. Gettys
Differential coupling of beta3A- and beta3B-adrenergic receptors to endogenous and chimeric G{alpha}s and G{alpha}i
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E704 - E715.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.